Avoid common mistakes on your manuscript.
1 Correction to: Drugs (2020) 80:1455–1464 https://doi.org/10.1007/s40265-020-01385-x
Correction in reviewer name:
Page 1455: The listing of the reviewer names and affiliations, which previously read:
N. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI, USA; C. Cerchione, Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy; S. Knop, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany; S. J. Kumar, Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
should read:
N. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI, USA; C. Cerchione, Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy; S. Knop, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany; S. K. Kumar, Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lamb, Y.N. Correction to: Daratumumab: A Review in Combination Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma. Drugs 81, 183 (2021). https://doi.org/10.1007/s40265-020-01455-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-020-01455-0